MedTrace Logo

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2025-11-18

No results posted yet for this study

Summary

The study aims at developping and validating an integrated clinico-molecular model for an accurate identification of FL patients who are progression free and progressed, respectively, at 24 months after treatment.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    collaborator OTHER

  • Azienda USL Reggio Emilia - IRCCS

    collaborator OTHER_GOV

  • Institute of Pathology, Locarno, Ticino, Switzerland

    collaborator UNKNOWN

  • Oncology Institute of Southern Switzerland

    lead OTHER

Principal Investigators

  • Davide Rossi, MD, PhD · Oncology Institute of Southern Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2021-10-31
Completion
2026-10-31

Countries

  • Italy
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436602 on ClinicalTrials.gov